Literature DB >> 15986864

Evaluation of five probiotic products for label claims by DNA extraction and polymerase chain reaction analysis.

Jeanne Drisko1, Bette Bischoff, Cheryl Giles, Martin Adelson, Raja-Venkitesh S Rao, Richard McCallum.   

Abstract

Label claims were evaluated for five probiotic products. Specific oligonucleotide primers were designed for 11 species from the Bifidobacterium, Lactobacillus, and Streptococcus genera. Polymerase chain reaction, gel electrophoresis, and amplicon excision with DNA sequencing were performed: Sequence analysis and DNA homology comparisons followed. Bifidobacterium bifidum was not detected in two of the five samples by PCR analysis. Also, Lactobacillus species were found in two of the five product samples for which the species was not listed as an ingredient. We conclude that (1) lack of B. bifidum in two probiotic products may be attributed to different preparation standards among probiotic manufacturers, and (2) identificaition of additional Lactobacillus species may represent contamination of the samples related to the fact that manufacturers utilize shared equipment to produce all probiotics and PCR is a highly sensitive technique.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15986864

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  7 in total

1.  Deficiencies in microbiological quality and labelling of probiotic supplements.

Authors:  J M T Hamilton-Miller; S Shah
Journal:  Int J Food Microbiol       Date:  2002-01-30       Impact factor: 5.277

Review 2.  Commensal host-bacterial relationships in the gut.

Authors:  L V Hooper; J I Gordon
Journal:  Science       Date:  2001-05-11       Impact factor: 47.728

Review 3.  Probiotics: future directions.

Authors:  J A Vanderhoof
Journal:  Am J Clin Nutr       Date:  2001-06       Impact factor: 7.045

Review 4.  Probiotics in health maintenance and disease prevention.

Authors:  Jeanne A Drisko; Cheryl K Giles; Bette J Bischoff
Journal:  Altern Med Rev       Date:  2003-05

5.  Rapid identification of 11 human intestinal Lactobacillus species by multiplex PCR assays using group- and species-specific primers derived from the 16S-23S rRNA intergenic spacer region and its flanking 23S rRNA.

Authors:  Y Song; N Kato; C Liu; Y Matsumiya; H Kato; K Watanabe
Journal:  FEMS Microbiol Lett       Date:  2000-06-15       Impact factor: 2.742

6.  Survival of Lactobacillus delbrueckii subsp. bulgaricus and Streptococcus thermophilus in the terminal ileum of fistulated Göttingen minipigs.

Authors:  S Lick; K Drescher; K J Heller
Journal:  Appl Environ Microbiol       Date:  2001-09       Impact factor: 4.792

Review 7.  Probiotics in infective diarrhoea and inflammatory bowel diseases.

Authors:  P Gionchetti; F Rizzello; A Venturi; M Campieri
Journal:  J Gastroenterol Hepatol       Date:  2000-05       Impact factor: 4.029

  7 in total
  11 in total

Review 1.  Future novel therapeutic agents for Clostridium difficile infection.

Authors:  Hoonmo L Koo; Kevin W Garey; Herbert L Dupont
Journal:  Expert Opin Investig Drugs       Date:  2010-07       Impact factor: 6.206

2.  Lactobacillus Casei Decreases Organophosphorus Pesticide Diazinon Cytotoxicity in Human HUVEC Cell Line.

Authors:  Hasan Bagherpour Shamloo; Saber Golkari; Zeinab Faghfoori; AliAkbar Movassaghpour; Hajie Lotfi; Abolfazl Barzegari; Ahmad Yari Khosroushahi
Journal:  Adv Pharm Bull       Date:  2016-06-30

Review 3.  The microbiome and probiotics in childhood.

Authors:  Michael Harrison Hsieh
Journal:  Semin Reprod Med       Date:  2014-01-03       Impact factor: 1.303

4.  Guide to designing, conducting, publishing and communicating results of clinical studies involving probiotic applications in human participants.

Authors:  Andi L Shane; Michael D Cabana; Stéphane Vidry; Dan Merenstein; Ruben Hummelen; Collin L Ellis; James T Heimbach; Susanne Hempel; Susan V Lynch; Mary Ellen Sanders; Daniel J Tancredi
Journal:  Gut Microbes       Date:  2010-06-16

5.  The human microbiome and probiotics: implications for pediatrics.

Authors:  Michael H Hsieh; James Versalovic
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2008 Nov-Dec

6.  Anti-inflammatory effect of bioflora probiotic administered orally or subcutaneously with live or dead bacteria.

Authors:  Om Laudanno; L Vasconcelos; J Catalana; Ja Cesolari
Journal:  Dig Dis Sci       Date:  2006-11-02       Impact factor: 3.487

7.  Culture-Independent Metagenomic Surveillance of Commercially Available Probiotics with High-Throughput Next-Generation Sequencing.

Authors:  Jennifer N Patro; Padmini Ramachandran; Tammy Barnaba; Mark K Mammel; Jada L Lewis; Christopher A Elkins
Journal:  mSphere       Date:  2016-03-30       Impact factor: 4.389

8.  Compositional Quality and Potential Gastrointestinal Behavior of Probiotic Products Commercialized in Italy.

Authors:  Alessandra Vecchione; Francesco Celandroni; Diletta Mazzantini; Sonia Senesi; Antonella Lupetti; Emilia Ghelardi
Journal:  Front Med (Lausanne)       Date:  2018-03-07

9.  Identification of Bacillus species: Implication on the quality of probiotic formulations.

Authors:  Francesco Celandroni; Alessandra Vecchione; Alice Cara; Diletta Mazzantini; Antonella Lupetti; Emilia Ghelardi
Journal:  PLoS One       Date:  2019-05-20       Impact factor: 3.240

10.  Probiotics in the arabian gulf region.

Authors:  Abiola C Senok
Journal:  Food Nutr Res       Date:  2009-03-04       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.